Analysis of gene expression profiles, from more than 2200 patients with breast cancer, revealed that CERK expression was associated with an increased risk of recurrence in women with breast cancer [64], suggesting that targeting this pro-survival enzyme may be highly beneficial to overcome this disease. Here, CERK is linked to breast cancer.